Dental Implants with a Calcium Ions-Modified Surface and Platelet Concentrates for the Rehabilitation of Medically Compromised Patients: A Retrospective Study with 5-Year Follow-Up

Overview

Journal Materials (Basel)

Publisher MDPI

Date 2021 Jun 2

PMID 34064086

Citations 5

Authors

Marco Mozzati

Giorgia Gallesio

Giulio Menicucci

Carlo Manzella

Margherita Tumedei

Massimo Del Fabbro

Affiliations

Soon will be listed here.

Abstract

Background: Platelet concentrates are biological, autologous products obtained from the patient's whole blood, consisting of a supraphysiological concentration of platelets and growth factors, that have proved beneficial in different applications in the medical and dental fields. They are used in several medical and dental applications to enhance tissue healing. Previous evidence shows that platelet concentrates may be beneficial in patients with compromised systemic conditions, in which the healing process is impaired.

Aim: To evaluate the 5-year clinical outcome of implant treatment using acid-etched implants with calcium ions-modified surface in association with plasma rich in growth factors, in patients with systemic diseases of a different nature.

Methods: Charts of 99 medically compromised patients, who had received a total of 224 dental implants from January 2013 to June 2013, were retrospectively evaluated. Patients were divided into four groups, according to their condition: diabetes (n = 39 patients), osteoporosis (n = 36), lupus erythematosus systemic (n = 5), rheumatoid arthritis (n = 19). The main outcomes were implant survival, marginal bone level (MBL) change and complications throughout follow-up.

Results: Mean follow-up was 63.06 ± 1.90 months (range 60.1 to 66.4 months). In total, eight implants failed in 6 diabetic patients and 4 in 3 patients with rheumatoid arthritis. Overall 5-year implant survival was 94.6%. In total, 30 complications occurred in 24 patients, mostly transient, and no severe adverse event occurred. Overall MBL change was 0.45 ± 0.12 mm, with no significant differences among groups.

Conclusions: In the present sample of medically compromised patients, rehabilitation with calcium ions-modified surface implants associated with plasma rich in growth factors proved to be a safe and effective treatment. The satisfactory results achieved after 5-year follow-up are comparable to those historically reported for healthy patients.

Citing Articles

The Effect of Oral Potentially Malignant Disorders (OPMD) on Dental Implants Survival-A Systematic Review.

Kaya S, Walter C, Khamis A, Muller-Heupt L, Zimmer S, Cascant Ortolano L Dent J (Basel). 2025; 13(1).

PMID: 39851611 PMC: 11763872. DOI: 10.3390/dj13010035.

Implant Treatment in Patients With Autoimmune Diseases: A Systematic Review and Analysis of Studies.

Sarafidou K, Lekatsa M, Michou A, Bakopoulou A, Poulopoulos A, Andreadis D Cureus. 2024; 16(8):e67617.

PMID: 39310633 PMC: 11416833. DOI: 10.7759/cureus.67617.

Survival and Success of Dental Implants in Patients with Autoimmune Diseases: a Systematic Review.

Hyldahl E, Gotfredsen K, Pedersen A, Jensen S J Oral Maxillofac Res. 2024; 15(1):e1.

PMID: 38812949 PMC: 11131373. DOI: 10.5037/jomr.2024.15101.

Systemic Diseases and Biological Dental Implant Complications: A Narrative Review.

Sbricoli L, Bazzi E, Stellini E, Bacci C Dent J (Basel). 2023; 11(1).

PMID: 36661547 PMC: 9857470. DOI: 10.3390/dj11010010.

Unusual Indications of Teeth Transplantation: A Literature Review.

Al-Khanati N, Albassal A, Beit Z Cureus. 2022; 14(9):e29030.

PMID: 36237754 PMC: 9552854. DOI: 10.7759/cureus.29030.

References

Goldin A, Beckman J, Schmidt A, Creager M . Advanced glycation end products: sparking the development of diabetic vascular injury. Circulation. 2006; 114(6):597-605. DOI: 10.1161/CIRCULATIONAHA.106.621854. View

Anitua E, Prado R, Orive G, Tejero R . Effects of calcium-modified titanium implant surfaces on platelet activation, clot formation, and osseointegration. J Biomed Mater Res A. 2014; 103(3):969-80. DOI: 10.1002/jbm.a.35240. View

Mozzati M, Gallesio G, di Romana S, Bergamasco L, Pol R . Efficacy of plasma-rich growth factor in the healing of postextraction sockets in patients affected by insulin-dependent diabetes mellitus. J Oral Maxillofac Surg. 2013; 72(3):456-62. DOI: 10.1016/j.joms.2013.10.010. View

Parihar A, Madhuri S, Devanna R, Sharma G, Singh R, Shetty K . Assessment of failure rate of dental implants in medically compromised patients. J Family Med Prim Care. 2020; 9(2):883-885. PMC: 7113960. DOI: 10.4103/jfmpc.jfmpc_989_19. View

Fabbro M, Bortolin M, Taschieri S . Is autologous platelet concentrate beneficial for post-extraction socket healing? A systematic review. Int J Oral Maxillofac Surg. 2011; 40(9):891-900. DOI: 10.1016/j.ijom.2011.04.009. View

Fabbro M, Ceresoli V, Lolato A, Taschieri S . Effect of platelet concentrate on quality of life after periradicular surgery: a randomized clinical study. J Endod. 2012; 38(6):733-9. DOI: 10.1016/j.joen.2012.02.022. View

Mozzati M, Arata V, Giacomello M, Fabbro M, Gallesio G, Mortellaro C . Failure risk estimates after dental implants placement associated with plasma rich in growth factor-Endoret in osteoporotic women under bisphosphonate therapy. J Craniofac Surg. 2015; 26(3):749-55. DOI: 10.1097/SCS.0000000000001535. View

Weinstein R . Glucocorticoid-induced osteonecrosis. Endocrine. 2011; 41(2):183-90. PMC: 3712793. DOI: 10.1007/s12020-011-9580-0. View

Brownlee M, Cerami A, Vlassara H . Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications. N Engl J Med. 1988; 318(20):1315-21. DOI: 10.1056/NEJM198805193182007. View

10.

Fabbro M, Corbella S, Ceresoli V, Ceci C, Taschieri S . Plasma Rich in Growth Factors Improves Patients' Postoperative Quality of Life in Maxillary Sinus Floor Augmentation: Preliminary Results of a Randomized Clinical Study. Clin Implant Dent Relat Res. 2013; 17(4):708-16. DOI: 10.1111/cid.12171. View

11.

den Broeder A, Creemers M, Fransen J, de Jong E, de Rooij D, Wymenga A . Risk factors for surgical site infections and other complications in elective surgery in patients with rheumatoid arthritis with special attention for anti-tumor necrosis factor: a large retrospective study. J Rheumatol. 2006; 34(4):689-95. View

12.

Pellegrini G, Francetti L, Barbaro B, Fabbro M . Novel surfaces and osseointegration in implant dentistry. J Investig Clin Dent. 2018; 9(4):e12349. DOI: 10.1111/jicd.12349. View

13.

Ruggiero S, Dodson T, Fantasia J, Goodday R, Aghaloo T, Mehrotra B . American Association of Oral and Maxillofacial Surgeons position paper on medication-related osteonecrosis of the jaw--2014 update. J Oral Maxillofac Surg. 2014; 72(10):1938-56. DOI: 10.1016/j.joms.2014.04.031. View

14.

Anitua E, Pinas L, Murias A, Prado R, Tejero R . Effects of calcium ions on titanium surfaces for bone regeneration. Colloids Surf B Biointerfaces. 2015; 130:173-81. DOI: 10.1016/j.colsurfb.2015.04.006. View

15.

Anitua E . Plasma rich in growth factors: preliminary results of use in the preparation of future sites for implants. Int J Oral Maxillofac Implants. 1999; 14(4):529-35. View

16.

Anitua E, Prado R, Troya M, Zalduendo M, Fuente M, Pino A . Implementation of a more physiological plasma rich in growth factor (PRGF) protocol: Anticoagulant removal and reduction in activator concentration. Platelets. 2016; 27(5):459-66. DOI: 10.3109/09537104.2016.1143921. View

17.

Mozzati M, Martinasso G, Pol R, Polastri C, Cristiano A, Muzio G . The impact of plasma rich in growth factors on clinical and biological factors involved in healing processes after third molar extraction. J Biomed Mater Res A. 2010; 95(3):741-6. DOI: 10.1002/jbm.a.32882. View

18.

Scully C, Hobkirk J, Dios P . Dental endosseous implants in the medically compromised patient. J Oral Rehabil. 2007; 34(8):590-9. DOI: 10.1111/j.1365-2842.2007.01755.x. View

19.

Malik A, Shaari R, Rahman S, Aljuboori M . Influence of platelet-rich plasma on dental implants. Osseointegration in well-controlled diabetic patients. Dent Implantol Update. 2012; 23(12):89-96. View

20.

Fabbro M, Karanxha L, Panda S, Bucchi C, Nadathur Doraiswamy J, Sankari M . Autologous platelet concentrates for treating periodontal infrabony defects. Cochrane Database Syst Rev. 2018; 11:CD011423. PMC: 6517213. DOI: 10.1002/14651858.CD011423.pub2. View